文献速递肝病消化道肿瘤与早癌

一种新的肝细胞癌等待名单脱落评分:识别预测移植后生存更差的阈值

A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival.
PubMed 文献 · J Hepatol · 2020-11-11

本研究基于UNOS数据库2010-2014年T2期肝细胞癌优先等待名单患者,在长等待区域开发脱落风险评分并在短、中等待区域验证。评分含肿瘤数目/大小、AFP>20 ng/ml、Child-Pugh和MELD-Na评分,C统计量0.74。评分>30者5年移植后生存60.1%,≤30者为71.8%(p=0.004)。

要点

  • 脱落风险评分>30的HCC患者移植后5年生存显著更差(60.1% vs 71.8%)。
  • 评分≤30时,可按预测脱落风险分层分配优先权而不影响移植后生存。
  • 评分基于肿瘤特征、AFP及肝功能指标,C统计量0.74。

核心结论

  • HCC等待名单脱落风险最高的患者具有侵袭性肿瘤生物学,即使快速移植移植后结局也差。
  • 脱落风险评分>30可识别移植后生存更差的患者,≤30时优先分配不影响移植后生存。

研究设计与样本

  • 基于UNOS数据库的回顾性队列研究,纳入2010-2014年T2期HCC优先等待名单患者。
  • 开发队列为长等待区域2092例,验证队列为短等待区域1735例和中等待区域2894例。

主要发现

  • 多变量分析显示1个肿瘤(3.1-5 cm)或2-3个肿瘤、AFP>20 ng/ml、Child-Pugh和MELD-Na评分升高显著预测等待名单脱落。
  • 4变量脱落风险评分C统计量0.74,1年累积脱落率从评分≤7的7.1%至评分>23的39.5%。
  • 评分>30者5年移植后生存60.1%,≤30者为71.8%(p=0.004),低于该阈值无显著差异。

关键数值与推荐

  • 脱落风险评分>30对应5年移植后生存60.1%,≤30对应71.8%(p=0.004)。
  • 评分≤7的1年累积脱落率为7.1%,评分>23为39.5%。

临床怎么用

  • 对于HCC等待名单患者,可计算脱落风险评分,评分≤30时按预测脱落风险分层分配优先权而不显著影响移植后生存。
  • 评分>30提示移植后生存可能较差,需谨慎评估优先移植策略。

局限性

  • 研究为回顾性数据库分析,未报告前瞻性验证。
  • 原文未报告其他局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: It has been suggested that patients with hepatocellular carcinoma (HCC) at high risk of wait-list dropout would have done poorly after liver transplantation (LT) because of tumour aggressiveness. To test this hypothesis, we analysed risk of wait-list dropout among patients with HCC in long-wait regions (LWRs) to create a dropout risk score, and applied this score in short (SWRs) and mid-wait regions (MWRs) to evaluate post-LT outcomes. We sought to identify a threshold in dropout risk that predicts worse post-LT outcome. METHODS: Using the United Network for Organ Sharing database, including all patients with T2 HCC receiving priority listing from 2010 to 2014, a dropout risk score was created from a developmental cohort of 2,092 patients in LWRs, and tested in a validation cohort of 1,735 patients in SWRs and 2,894 patients in MWRs. RESULTS: On multivariable analysis, 1 tumour (3.1-5 cm) or 2-3 tumours, alpha-fetoprotein (AFP) >20 ng/ml, and increasing Child-Pugh and model for end-stage liver disease-sodium scores significantly predicted wait-list dropout. A dropout risk score using these 4 variables (C-statistic 0.74) was able to stratify 1-year cumulative incidence of dropout from 7.1% with a score ≤7 to 39.5% with a score >23. Patients with a dropout risk score >30 had 5-year post-LT survival of 60.1% vs. 71.8% for those with a score ≤30 (p = 0.004). There were no significant differences in post-LT survival below this threshold. CONCLUSIONS: This study provided evidence that patients with HCC with the highest dropout risk have aggressive tumour biology that would also result in poor post-LT outcomes when transplanted quickly. Below this threshold risk score of ≤30, priority status for organ allocation could be stratified based on the predicted risks of wait-list dropout without significant differences in post-LT survival. LAY SUMMARY: Prioritising patients with hepatocellular carcinoma for liver transplant based on risk of wait-list dropout has been considered but may lead to inferior post-transplant survival. In this study of nearly 7,000 patients, we created a threshold dropout risk score based on tumour and liver-related factors beyond which patients with hepatocellular carcinoma will likely have poor post-liver transplant outcomes (60% at 5 years). For patients below this risk score threshold, priority status could be stratified based on the predicted risk of wait-list dropout without compromising post-transplant survival.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Mehta N, Dodge JL, Roberts JP, et al. A novel waitlist dropout score for hepatocellular carcinoma - identifying a threshold that predicts worse post-transplant survival. J Hepatol. 2020. PMID: 33188904. doi:10.1016/j.jhep.2020.10.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。